Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Open-Label, Phase II/III Clinical Trial Evaluating the Efficacy and Safety of a Fixed Combination of Ketorolac / Pitofenone / Fenpiverinium Compared to Active Control in Patients With Pain After Surgical Abdominal and Pelvic Operations

NCT05607641 is registered in ClinicalTrials.gov with Darnitsa Pharmaceutical Company as lead sponsor.

NCT NCT05607641
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05607641 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Open-Label, Phase II/III Clinical Trial Evaluating the Efficacy and Safety of a Fixed Combination of Ketorolac / Pitofenone / Fenpiverinium Compared to Active Control in Patients With Pain After Surgical Abdominal and Pelvic Operations
Lead sponsor
Darnitsa Pharmaceutical Company
Phase
Phase 2/3
Overall status
Completed
Start date
July 7, 2021
Completion date
May 13, 2022
Enrollment
424 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

postsurgical pain